Deepening industry roots and integrating global supply and demand—CPHI & PMEC China charts a new course for Chinese pharmaceuticals going global.

With the implementation of new industry regulations, a fresh wave of development is gathering momentum. The Regulations on the Clinical Research and Clinical Translation of New Biomedical Technologies (Order No. 818) officially came into force on May 1, 2026, clearly delineating the regulatory boundaries between new biomedical technologies and pharmaceuticals and medical devices, thereby ushering China’s oversight of such technologies into a new phase of refined, structured governance. In the same month, the 2025 Drug Review Report was formally released, painting a comprehensive picture of the Chinese pharmaceutical sector’s entry into a new stage of opening-up. Independent innovation and differentiated development have become core pillars of the industry, charting a clear path for Chinese pharmaceutical companies as they expand globally.

 

After years of dedicated development and continuous iteration, China’s pharmaceutical industry has moved beyond a follower‑driven growth model and now ranks among the global leaders in innovative new‑drug research and development. In an era of deepening international trade integration, domestically produced pharmaceuticals not only fully meet domestic public health needs but also leverage their core advantages—high cost‑effectiveness and superior quality—to expand into global markets, offering the world mature and reliable Chinese‑made healthcare solutions. At this pivotal moment, marked by industrial upgrading and opening up to the world, a premier annual industry event that brings together pharmaceutical professionals from across the globe is set to kick off in Shanghai.

 

The flagship pharmaceutical industry event—the 24th CPHI China 2026, co‑organized by Informa Markets, the China Chamber of Commerce for Import & Export of Medicines & Health Products, and Shanghai BoHua International Exhibition Co., Ltd.—will be held alongside the 19th PMEC China 2026, the World Pharmaceutical Machinery, Packaging Equipment & Materials Exhibition. Together, these two premier trade shows will transform the Shanghai New International Expo Center (Pudong) into a global hub for pharmaceutical trade, enabling China’s pharmaceutical sector to seize cross‑border business opportunities without leaving Shanghai.

01

Empowering through the aggregation of end-to-end resources.

Business and trade connectivity to jointly expand globally.

An enormous area of 250,000 square meters

36 large exhibition halls

More than 3,700 companies are exhibiting.

Over 110,000 professional buyers from home and abroad

Are you facing these challenges?

🔍 Want to gain direct access to high-quality suppliers at home and abroad? Expand compliant, diversified procurement channels? Strengthen your company’s supply chain system?

🔍 Gaining insights into the evolving industry landscape? Uncovering sector‑specific opportunities? How can you develop a global strategy?

🔍 Want to learn about cutting-edge technologies and innovative breakthroughs in global pharmaceuticals? Looking to broaden your research horizons?

🔍 Want to observe advanced manufacturing in smart production and green, low-carbon processes? Looking to upgrade your production management and control system?

🔍 Want to stay up-to-date on the latest regulatory policies, industry compliance standards, and practical implementation guidelines—both domestically and internationally?

🔍 How can you confidently address the diverse needs of international registration and compliant operations?

The exhibition precisely addresses the pain points of corporate development, tackles industry challenges, and creates an end-to-end platform that integrates trade matchmaking, technological exchange, and solution implementation, covering the developmental needs of all functional areas within pharmaceutical companies. Whether you are a senior decision-maker mapping out your company’s future strategy, a research and development elite dedicated to pioneering new drugs and technologies, a production or engineering professional on the front lines, a procurement and supply-chain specialist managing material flows, or a regulatory affairs expert focused on compliance, you can discover high‑quality resources, share industry insights, and identify tailored, high‑caliber solutions that align with both your work and your organization’s growth.

During the exhibition, leading domestic companies made high‑profile appearances, presenting an impressive lineup that included Huahai Pharmaceutical, Jiuzhou Pharmaceutical, Haizheng Pharmaceutical, Chuangnuo Pharmaceutical, Qilu Pharmaceutical, Shiyao Group, North China Pharmaceutical, Yiling Wanzhou, Luoxin, Ashland, Roquette, Kailain, Ganlee Pharmaceutical, Chenguang Bio, Yuwang Pharmaceutical, Dongfulong, Chutian Technology, Xinhua Medical, Canaan Technology, Duoning Bio, Hanbang Technology, SCHOTT, Weigao Pure, SenSong, United Pharma…

 

The overseas exhibitor lineup has been comprehensively refreshed, bringing together global innovation and attracting companies from 33 countries and regions, including the United States, Germany, Italy, Spain, South Korea, and more. Exhibitors such as Alivus Life Sciences, Almac Group, AMGIS LIFESCIENCE, Anmol Chemicals, AROMATICS, CDMO & Services powered by Neuca Group, Cryoport Systems, CURAPATH, CurTec, Delta Finochem, DINERAS, UAB, Evonik Industries, FAMAR, HISPANAGAR, HTBA, Indus Biotech, Inpac Pharma, Micro-Pak, MORGAN CHEMICALS, Oceanic Pharmachem, Octapharma AG, PATELCHEM SPECIALTIES, Rephine Barcelona SLU, Schrodinger, Shin NipponYakugyo, SHINKO, SNA Healthcare, SP ACCURE LABS, UNIFARMA SIA, VITAL SYNTHETICLABS, and many others will be showcased across halls E1, E1.1, E2, E3, N3, N5, and W5, offering the industry a wealth of diversified opportunities for international collaboration.

02

Deeply cultivate diverse niche markets.

Unlocking New Opportunities Across All Sectors

This year’s exhibition focuses on a wide array of hot‑ticket niche segments, strategically positioning itself across key areas such as the greater health sector, medical aesthetics and functional skincare, the modernization of traditional Chinese medicine, out-of‑hospital channels, smart laboratories, and life sciences. By efficiently connecting supply and demand, it empowers buyers in these specialized markets to access cutting-edge solutions.

[Natural Health, Empowering Food-Nutrition Innovation]

Tailored to meet the needs of health‑food companies, this event offers a diverse array of high‑quality products and complementary resources. Onsite, it brings together premium raw and auxiliary ingredients, cutting‑edge production equipment, and packaging materials—covering every aspect of new‑product development, product iteration, quality enhancement, and large‑scale manufacturing. It helps businesses swiftly expand into hot health‑food segments such as gut health, weight management, anti‑aging and nourishment, and immune regulation.

Event Recommendations:

The 19th Symposium on Innovation and Development in Natural Extracts

2026 Natural Ingredients Innovation and Health Applications Conference

Main Forum: Innovation in Practice – Global Trends in Food Ingredient Regulation and Compliance Practices

Forum 1: Evidence-Based Innovation and Real-World Implementation of Plant-Based Solutions and Food-as-Medicine Approaches

Forum II: R&D Innovation in Weight Management and Sports Nutrition, 2026

Forum 3: Insights into 2026 Trends in the Gut Health Industry and Raw Material Innovation, plus Cutting-Edge Insights on Functional Food Ingredients for 2026

[Medical Aesthetics and Skincare: Driving Industry Upgrading]

Covering core upstream resources in the medical aesthetics and skincare sectors—including injectable raw materials, functional ingredients, bio‑derived actives, and cosmetic‑grade excipients—this platform brings together premium OEM/ODM manufacturers, pharmaceutical‑medical device combinations, quality‑testing services, compliance consulting, and intelligent production equipment providers. It streamlines the entire end‑to‑end process—from R&D and manufacturing to packaging, testing, and regulatory filing—offering a one‑stop, comprehensive solution for medical aesthetic clinics, beauty brands, and contract manufacturers. Notably, the “Pharmaceutical‑Medical Device Integration Zone” and the “Medical Aesthetics Packaging Zone” focus on hot‑ticket areas such as injectable fillers, post‑procedure recovery, and consumables, helping exhibitors connect with key decision‑makers at leading medical aesthetic brands and seize market opportunities and collaboration advantages.

Event Recommendations:

2026 Pharmaceutical Raw Materials, Technology, and Distribution Channels Empowerment Symposium on Innovative Development in the Cosmetics Industry

The 4th CPHI Anti-Aging Themed Forum

Skin Research for Beauty: Advancing with Compliance — Forum on the Development of Dermatology and Medical Aesthetic Applications

2026 Injection-Based Medical Aesthetics Quality Control Forum

“Gathering Momentum in Medical Aesthetics: Symbiotic Growth Across the Entire Value Chain” Themed Forum

Theme One: Product Upgrades Empower Medical Aesthetics Enterprises to Enhance Their Services

Theme 2: Reducing the Need for Repeated Doses—A Guide to Preclinical Testing and Animal Studies in Medical Aesthetics

Theme 3: Going Global Across All Markets—The Path to Breaking the Impasse in the Medical Aesthetics Industry

Theme Four: Capital Synergy—Co‑Building a New Ecosystem for the Medical Aesthetics Industry and a Journey to Explore Premium Cosmetic Ingredients

[Herbal Medicine Heritage Accelerates Global Expansion]

Hall E5’s Natural Products Pavilion features a dedicated zone for traditional Chinese medicinal materials and processed herbal slices, showcasing authentic TCM herbs, ready-to-use TCM decoction pieces, and food‑medicine‑based nourishing ingredients. This initiative supports the industry’s integration into the global market and unlocks new momentum for the modernization and internationalization of TCM. We warmly invite industry partners to gather on site to select premium products, expand distribution channels, and explore collaborative opportunities, together seizing fresh prospects in the TCM sector!

Event Recommendations:

2026 Symposium on the Modernization and Internationalization of Traditional Chinese Medicine

Chinese Herbal Medicine and Sliced Herbal Products Section

[Off‑site channels, unlocking incremental sales at the point of sale]

This year’s pharmaceutical formulation exhibition boasts a formidable lineup, bringing together leading companies such as Chenxin Pharmaceutical, Shijiazhuang Sihua Pharmaceutical, Xuantai Pharmaceutical, Nanjing Jianyou, CSPC Pharmaceutical Group, Yiling Wanzhou, Huiyu Pharmaceutical, Lianhuan Pharmaceutical, Hengrui Medicine, Maijin Bio, Zhejiang Medicine, Borui Pharmaceutical, Aoruite, Fuan Pharmaceutical, Ha Sanlian, and HaiZheng Pharmaceutical. Concurrent with the event, a series of specialized forums will be held, offering in-depth discussions on industry‑wide hot topics, including off‑hospital prescription circulation and retail channel expansion.

Event Recommendations:

Professional Pharmacy Collaboration and In-Hospital/Out-of-Hospital Coordination: Breaking the Impasse—In-Hospital/Out-of-Hospital Integrated Marketing and Prescription Referral Innovation Forum

[Smart Laboratories: Reshaping the Research Paradigm]

In response to the wave of digital transformation and intelligent development, this year’s exhibition has unveiled a state-of-the-art smart laboratory in Hall W16, bringing together industry leaders such as CETC Fourth Institute, Honeywell, Testo, Anton Paar, Rongyu Wisdom, Yishi Technology, LabVantage, NEA, and Dashengdete. The exhibit features immersive, interactive experiences that are both visually engaging and hands-on, addressing key industry challenges—including fragmentation, resource dispersion, and unclear transformation pathways—while helping to ensure that digital‑intelligence transformation strategies can be effectively implemented.

Event Recommendations:

Smart Laboratory Space Launch Ceremony

Smart Laboratory Innovation Roadshow and Intelligent Laboratory Innovation and Development Forum

Forum 1: Digital and Intelligent Transformation and Development of Laboratories

Forum II: Digital and Intelligent Applications in Laboratories
[Life Sciences: Pioneering the Next Wave of Industry Growth]

At a pivotal moment marked by the biopharmaceutical technology revolution and the reshaping of the global market landscape, this year’s exhibition continues to present a joint showcase dedicated to life sciences and biopharmaceuticals. Centered on the themes of “leading trends, end-to-end integration, and value creation,” it brings together resources from three core sectors—biotechnology, life-science instruments, and bioengineering—to build an international platform that spans the entire research‑to‑commercialization continuum. Concurrent forums will address pressing topics such as policy updates, cutting-edge technologies, quality control, and scalable manufacturing, fostering a symbiotic ecosystem that connects researchers, clinicians, industry players, government agencies, and investors.

Event Recommendations:

The 11th CPHI Forum on Biopharmaceutical Innovation, Development, and Cutting-Edge Advances

Drug Development and Technological Innovation Exchange Conference

TIDEs Drug Development and Industrialization Forum

2026 Forum on Innovative Development in Life Science and Technology & Special Symposium on Biologics CMC and Analytical Quality Control

2026 Biologics Commercial Manufacturing and Innovation Forum

03

Global passenger traffic is on the rise.

A grand event brings together forces to connect the world.

Leveraging its strong industry influence and international advantages, this year’s exhibition has seen a steady surge in overseas participation. According to the latest statistics, as of the end of May, the event has already registered over 20,000 global professional attendees—more than a 20% increase compared with the same period last year. In addition to the substantial growth in attendance, the sophistication and transactional value of overseas buyers are particularly noteworthy, with a sharp focus on meeting the core needs of industrial trade matchmaking. Data shows that among the pre-registered international visitors, 52% hold C‑level executive positions, including presidents, general managers, procurement directors, and chief technology officers—key decision‑makers across organizations. Meanwhile, 77% of registered attendees possess direct purchasing authority, enabling efficient alignment between supply and demand and the execution of commercial orders.

 

At present, the exhibition’s overseas registered audience spans 174 countries and regions worldwide. Among them, Pakistan, South Korea, Bangladesh, Russia, the Philippines, Indonesia, Nigeria, Egypt, the United States, and Japan rank among the top 10 in terms of engagement, covering key markets across Asia, Africa, the Americas, and beyond. This underscores the event’s diversified, global participation structure and highlights the pressing demand from markets around the world for cutting-edge technologies, innovative products, and robust business collaboration.

04

The forum unites forces to usher in a new journey of wisdom.

United in purpose, we forge a new chapter in global expansion.

In addition to specialized thematic seminars, a wealth of unique experiences awaits you! Enjoy premium product showcases, a dedicated incubation zone for debut brands, an exhibition area highlighting cutting-edge innovations, curated exploration tours, and one‑on‑one business matchmaking sessions—complemented by more than a dozen engaging themed photo‑ops, all designed to let you experience the industry’s latest trends in one convenient stop.

We cordially invite industry partners from around the world to join us at this premier pharmaceutical event in Shanghai.

Seize Industry Opportunities Together

Together, we’ll conquer the global market!